isoconazole has been researched along with triazoles in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bastide, JM; Bastide, M; Jouvert, S; Lebecq, JC; Mallie, M; Montes, B | 1 |
| Foleno, B; Isaacson, DM; Rosenthale, ME; Tolman, EL | 1 |
| Hiltl, BP; Münnich, W | 1 |
| Abbott, AB; Odds, FC; Webster, CE | 1 |
4 other study(ies) available for isoconazole and triazoles
| Article | Year |
|---|---|
[Comparative action of 8 azole derivatives against Candida albicans: fungistatic action and cytologic study by scanning electron microscopy].
Topics: Antifungal Agents; Candida albicans; Clotrimazole; Cytoplasm; Econazole; Imidazoles; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Spheroplasts; Triazoles | 1988 |
In vitro studies with terconazole.
Topics: Antifungal Agents; Candida albicans; Clotrimazole; Culture Media; Lactobacillus; Miconazole; Microbial Sensitivity Tests; Triazoles | 1985 |
Single-day topical treatment of vaginal candidosis: an open evaluation of terconazole 240-mg vaginal suppositories versus isoconazole tablets 600 mg.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; Miconazole; Suppositories; Tablets; Triazoles; Vagina | 1985 |
Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
Topics: Antifungal Agents; Aspergillus; Candida; Clotrimazole; Econazole; Imidazoles; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Morpholines; Triazoles | 1984 |